Accelerating the impact of science for a better future with @Parkwalk_VC - @nanopore @FLFusion @FeaturespaceLtd #backinginnovation🧬🧪🔬🔭
UK, USA, Australia, NZ
Joined July 2011
- Tweets3.3K
- Following2.6K
- Followers5.9K
- Likes2.5K
📬 The latest from IP Group and our portfolio is here! 🚀
Funding rounds, scientific breakthroughs and continued investment in UK spinouts – it’s been another busy month across IP Group and our portfolio.
Catch up on some of the highlights, including:
🔹 IP Group and @Parkwalk_VC remaining the most active investors in UK spinouts
🔹 Matter Machine’s oversubscribed £4m funding round, led by IP Group, and the appointment of Dr Gordon Sanghera CBE, co-founder and former CEO of @nanopore, to lead its commercial strategy.
🔹 @MicrobioticaLtd's £36m Series C financing to advance its pipeline of precision microbiome medicines.
🔹 @FLFusion’s major technical milestone, demonstrating the key fuel compression principle underpinning FLARE, its proprietary approach to inertial fusion.
👉 Read the newsletter – link in the comments below 👇
✉️ Want future editions delivered straight to your inbox? Subscribe here: bit.ly/4s0MsFd
#Innovation #DeepTech #HealthTech #ClimateTech 🚀🔬🌍
🔬The UK continues to produce world-class science and technology companies with UK university spinouts raising a remarkable £1.56bn in H1 2026, underlining the global appeal of British science and innovation.
Yet while investment remains strong, the latest @Parkwalk_VC and @Beauhurst Equity Investment into Spinouts report highlights a growing challenge: ensuring innovative businesses can access the scale-up capital they need to fulfil their potential.
In this interview with @proactive_x, our CEO Greg Smith discusses the report’s findings, exploring both the strength of the UK spinout ecosystem and why unlocking more domestic capital could help retain more of the value created by British innovation.
By helping more science-led companies scale in the UK, we can retain more of the value created by British universities for entrepreneurs, savers, the economy and society.
📽️ Watch the interview below.
#IPGroup #Parkwalk #Innovation #InvestingInScience #Spinouts #UKTech #Scaleups
IP Group highlights £1.56B UK spinout investment as scale-up funding gap widens @IPGroupplc proactiveinvestors.com/compa… #proactiveinvestord #ipgroupplc #lse #UKSpinouts #UniversitySpinouts #VentureCapital #Innovation #IPO
🚀Today, @Parkwalk_VC, our EIS fund manager, has published the 2026 Equity Investment into Spinoutsreport with @Beauhurst.
Brilliant to see IP Group and @Parkwalk_VC confirmed as the UK’s most active investors in spinouts. 🎉
📊 The report deep dives into the investment trends impacting the UK’s most promising science and technology companies. It reveals H1 2026 to have been a near-record half-year, with spinouts raising £1.56bn.
🔬British science is now attracting substantial later-stage investment, at £760m in H1 2026 – its highest half-year since 2021.
💡 With spinouts raising larger rounds, the report demonstrates the major opportunity for more domestic institutional capital to invest alongside – with significant value on offer for savers, entrepreneurs, the economy and society.
🤝 Together with Parkwalk, we have backed 42 deals over the past year and continue to play a leading role in supporting the sector with scale-up capital. We have now invested in 98 later-stage companies over the past decade.
📖Read the release in the link below 👇.
#IPGroup #Parkwalk #Innovation #InvestingInScience #Spinouts #UKTech #Scaleups
Great to hear @MicrobioticaLtd CEO Tim Sharpington talking about the company’s exciting next chapter following its £36m Series C raise.
IP Group is delighted to be continuing its support, investing a further £4m as Microbiotica prepares to advance MB310 into Phase 2 clinical trials for ulcerative colitis.
🎥 Hear from Tim about the encouraging clinical progress so far, the potential of microbiome-based therapeutics and what comes next for the business.
Microbiotica CEO on £36m raise to advance gut treatment into Phase 2; IP Group invests £4m @IPGroupplc proactiveinvestors.com/compa… #Microbiotica #Biome #Gut #Colitis #Microbiome #IPO
IP Group - visionary ventures retweeted
Microbiotica CEO on £36m raise to advance gut treatment into Phase 2; IP Group invests £4m @IPGroupplc proactiveinvestors.com/compa… #Microbiotica #Biome #Gut #Colitis #Microbiome #IPO
🧬 An exciting milestone for @MicrobioticaLtd.
We’re delighted to continue our support for Microbiotica, which has raised £36m to advance its pipeline of precision microbiome medicines.
Following positive Phase 1b results, the new funding will enable its lead programme, MB310, to progress into Phase 2 clinical development in ulcerative colitis.
We’re pleased to increase our investment alongside a high-quality syndicate including British Business Bank, Tencent, Cambridge Innovation Capital, Flerie Invest and Seventure Partners.
As our CEO Greg Smith puts it: “Microbiotica has made exciting progress in translating world-class microbiome science into potential new medicines for patients.”
Congratulations to the whole Microbiotica team on this important next step. 👏
#Microbiome #Biotech #LifeSciences #Innovation
We're delighted to be backing Matter Machine and to be working once again with Dr Gordon Sanghera, whose track record in translating breakthrough science into global commercial success speaks for itself.
From helping build @nanopore into one of the UK's leading technology companies to leading Matter Machine today, Gordon has consistently focused on turning world-class science into real-world impact.
🎥But don't just take our word for it. Hear Gordon explain why the team believes AI-powered materials discovery can help address some of society's biggest challenges.
We're proud to have led the company's oversubscribed £4m pre-Series A round and look forward to supporting the team as they build the next generation of materials technologies from world-leading research at the University of Liverpool.
IP Group's Matter Machine: Dr Gordon Sanghera sees 'urgent unmet need' for AI-discovered materials @IPGroupplc proactiveinvestors.com/compa… #IP #AI #Material #Nanopore #OxfordNanoporeTechnologies
IP Group - visionary ventures retweeted
$IPO IP Group leads funding round for University of Liverpool AI spin-out Matter Machine tinyurl.com/296jqes5 @IPGroupplc #IPO
🚀 We’re delighted to have led an oversubscribed £4m funding round for Matter Machine, an AI-driven materials discovery company spun out of @LivUni.
The funding will help accelerate the commercial development of its AI-powered platform, designed to dramatically speed up the discovery and optimisation of novel materials.
🤝We're pleased to be investing alongside Northern Gritstone, the University of Liverpool Enterprise Fund, Norrsken Evolve and LYVA Labs, as well as the Northern Universities Venture Fund managed by @Parkwalk_VC, our EIS fund management business. It's a strong syndicate backing a company with the potential to transform how new materials are discovered and developed.
🌟We’re also delighted to see Dr Gordon Sanghera CBE, co-founder and former CEO of @nanopore, joining Matter Machine to lead its commercial strategy. Having previously worked with Gordon throughout the growth of Oxford Nanopore, we know the experience and ambition he brings to building globally significant deeptech businesses.
👏Congratulations to the team. We look forward to supporting Matter Machine as it accelerates its growth and realises the potential of AI-powered materials discovery.
🌍Matter Machine exemplifies the kind of ambitious, science-led company IP Group was established to support: combining world-class research, exceptional entrepreneurial talent and the potential to create meaningful impact across industries.
Read more in the comments below 👇
#DeepTech #ArtificialIntelligence #MaterialsScience #Innovation #Spinouts #UniversityInnovation #VentureCapital #AI #IPGroup hashtag#InvestingInScience
🧬 Today we announced a c.£21m partial realisation of our holding in @nanopore, one of the most significant success stories in the IP Group portfolio.
📈 Following the transaction, IP Group remains one of Oxford Nanopore's largest shareholders, retaining a 7.23% stake.
The realisation demonstrates our ability to generate cash from maturing portfolio companies while maintaining meaningful exposure to future value creation. The proceeds further strengthen our financial flexibility and support disciplined capital allocation across the portfolio and broader Group priorities.
🚀 We remain strong supporters of Oxford Nanopore, its management team and its long-term prospects, and look forward to continuing that journey as a major shareholder.
As our CEO, Greg Smith, commented: "Oxford Nanopore has been one of the standout successes within our portfolio and we remain strong supporters of the company, its management team and its long-term prospects.”
Read more in the comments below 👇
#IPGroup #OxfordNanopore #DeepTech #LifeSciences #Innovation #InvestingInScience
25 years of backing science that matters 🔬
For the past quarter century, we've had the privilege of working with exceptional researchers, entrepreneurs, colleagues, investors and partners united by a belief that science and technology can change lives.
Together with @Parkwalk_VC, we've helped discover, back and scale hundreds of science and technology businesses, supporting innovations that are helping to build a healthier, tech-enriched and more regenerative future.
This animation captures a small part of the story so far, from research and discovery through to the businesses and innovations creating real-world impact today.
Thank you to everyone who has been part of the journey so far.
🚀 Here's to what's next.
#IPGroup #Parkwalk #Innovation #DeepTech #HealthTech #CleanTech #Science #VentureCapital #25Years
It's great to see portfolio company @nanopore featured in this @BBCNews story highlighting the potential of rapid genomic testing to transform brain tumour diagnosis.
Reducing the wait for an accurate diagnosis from weeks to hours could make a profound difference for patients and their families, helping clinicians make faster, more informed treatment decisions when time matters most.
Stories like this are a powerful reminder of the real-world impact that can come from turning breakthrough science into practical healthcare solutions.
🧬 Read the BBC article: From weeks to hours: the rapid new test transforming brain tumour diagnosis
bbc.co.uk/news/articles/cr3w…
#HealthcareInnovation #Genomics #OxfordNanopore #BrainTumourResearch #ImpactInvesting #ScienceThatMatters
🔬 A significant milestone for our portfolio company First Light Fusion.
Today, First Light announced the successful demonstration of a key fuel compression principle underpinning FLARE, its proprietary approach to inertial fusion.
What stands out is the commercial focus. The result supports an approach designed to reduce the power, complexity and cost traditionally associated with fusion systems, helping move the sector closer to economically viable fusion energy.
It's a great example of the deep scientific innovation emerging from the UK and of the patient, long-term development pathways often required to build transformational technologies.
Congratulations to the entire First Light team on another important milestone.
📖 Read more in the comments below 👇
#FusionEnergy #DeepTech #ClimateTech #EnergyTransition #Innovation
📅 MelloMonday | Monday 21 September | 5:00pm
We're looking forward to Chris Glasson, Finance Director at IP Group, presenting at MelloMonday next week and discussing how we're backing some of the UK's most exciting science and technology businesses. Chris will also take questions from attendees during the session.
We hope to see you there.
🎟️ bit.ly/4hhLoIZ
#MelloMonday #IPGroup #Parkwalk #Innovation #DeepTech #HealthTech #CleanTech #Science #VentureCapital #Investing
